Eleven Biotherapeutics

SEC Filings
 

 
SEC Filings
Date Filed Filing Description View
February 19, 2014 SC 13G statement of beneficial ownership HTML PDF XLS Add to Briefcase
February 18, 2014 8-K current report HTML PDF XLS Add to Briefcase
February 13, 2014 4 kania, edwin m jr HTML PDF XLS Add to Briefcase
February 13, 2014 SC 13D general statement of beneficial ownership HTML PDF XLS Add to Briefcase
February 13, 2014 4 tepper, robert i HTML PDF XLS Add to Briefcase
February 13, 2014 4 lynch, daniel HTML PDF XLS Add to Briefcase
February 12, 2014 4 jafco, super v3 investment limited partnership HTML PDF XLS Add to Briefcase
February 12, 2014 3 tepper robert i HTML PDF XLS Add to Briefcase
February 6, 2014 3 jafco super v3 investment limited partnership HTML PDF XLS Add to Briefcase
February 6, 2014 CT ORDER confidential treatment order HTML PDF
Add to Briefcase
FirstPrevious ...
22
NextLast
Add to Briefcase = add PDF file to Briefcase
NASDAQ: EBIO
Price:
1.47
Change:
+ 0.01
Day High:
1.50
Day Low:
1.43
Volume:
216,094
4:00 PM ET on June 22, 2017
Delayed at least 20 minutes.